BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 6090701)

  • 1. A 3' end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus.
    Chatis PA; Holland CA; Silver JE; Frederickson TN; Hopkins N; Hartley JW
    J Virol; 1984 Oct; 52(1):248-54. PubMed ID: 6090701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses.
    Chatis PA; Holland CA; Hartley JW; Rowe WP; Hopkins N
    Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4408-11. PubMed ID: 6308622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides.
    Li Y; Golemis E; Hartley JW; Hopkins N
    J Virol; 1987 Mar; 61(3):693-700. PubMed ID: 3468264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequences in the U5-gag-pol region influence early and late pathogenic effects of Friend and Moloney murine leukemia viruses.
    Sitbon M; Ellerbrok H; Pozo F; Nishio J; Hayes SF; Evans LH; Chesebro B
    J Virol; 1990 May; 64(5):2135-40. PubMed ID: 2182908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.
    Golemis E; Li Y; Fredrickson TN; Hartley JW; Hopkins N
    J Virol; 1989 Jan; 63(1):328-37. PubMed ID: 2783259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The envelope gene and long terminal repeat sequences contribute to the pathogenic phenotype of helper-independent Friend viruses.
    Oliff A; Signorelli K; Collins L
    J Virol; 1984 Sep; 51(3):788-94. PubMed ID: 6088801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
    Hanecak R; Pattengale PK; Fan H
    J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transcriptional enhancer with specificity for erythroid cells is located in the long terminal repeat of the Friend murine leukemia virus.
    Bösze Z; Thiesen HJ; Charnay P
    EMBO J; 1986 Jul; 5(7):1615-23. PubMed ID: 3462001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma.
    Savard P; DesGroseillers L; Rassart E; Poirier Y; Jolicoeur P
    J Virol; 1987 Oct; 61(10):3266-75. PubMed ID: 3041046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the viral sequences conferring leukemogenicity and disease specificity in Moloney and amphotropic murine leukemia viruses.
    DesGroseillers L; Jolicoeur P
    J Virol; 1984 Nov; 52(2):448-56. PubMed ID: 6092670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
    Brightman BK; Farmer C; Fan H
    J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 2.4-kilobase-pair fragment of the Friend murine leukemia virus genome contains the sequences responsible for friend murine leukemia virus-induced erythroleukemia.
    Oliff A; Ruscetti S
    J Virol; 1983 Jun; 46(3):718-25. PubMed ID: 6574260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus.
    Manley NR; O'Connell MA; Sharp PA; Hopkins N
    J Virol; 1989 Oct; 63(10):4210-23. PubMed ID: 2778872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses.
    Ishimoto A; Takimoto M; Adachi A; Kakuyama M; Kato S; Kakimi K; Fukuoka K; Ogiu T; Matsuyama M
    J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequences responsible for the distinctive hemolytic potentials of Friend and Moloney murine leukemia viruses are dispersed but confined to the psi-gag-PR region.
    Richardson J; Corbin A; Pozo F; Orsoni S; Sitbon M
    J Virol; 1993 Sep; 67(9):5478-86. PubMed ID: 8350407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo.
    Brightman BK; Rein A; Trepp DJ; Fan H
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2264-8. PubMed ID: 2006167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subgenomic fragment of molecular cloned Friend murine leukemia virus DNA contains the gene(s) responsible for Friend murine leukemia virus-induced disease.
    Oliff A; Linemeyer D; Ruscetti S; Lowe R; Lowy DR; Scolnick E
    J Virol; 1980 Sep; 35(3):924-36. PubMed ID: 6252347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
    Fan H; Mittal S; Chute H; Chao E; Pattengale PK
    J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA element responsible for the different tissue specificities of Friend and Moloney retroviral enhancers.
    Thiesen HJ; Bösze Z; Henry L; Charnay P
    J Virol; 1988 Feb; 62(2):614-8. PubMed ID: 2826819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic basis of disease specificity of nondefective Friend murine leukemia virus.
    Hopkins N
    Ann N Y Acad Sci; 1989; 567():14-25. PubMed ID: 2679314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.